These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 681879
1. The human complement system in thrombin-mediated platelet function. Polley MJ, Nachman R. J Exp Med; 1978 Jun 01; 147(6):1713-26. PubMed ID: 681879 [Abstract] [Full Text] [Related]
2. Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. Polley MJ, Nachman RL. J Exp Med; 1979 Sep 19; 150(3):633-45. PubMed ID: 479764 [Abstract] [Full Text] [Related]
3. Human complement in the arachidonic acid transformation pathway in platelets. Polley MJ, Nachman RL, Weksler BB. J Exp Med; 1981 Feb 01; 153(2):257-68. PubMed ID: 7241047 [Abstract] [Full Text] [Related]
5. Secretion of the terminal complement proteins, C5-C9, by human platelets. Houle JJ, Leddy JP, Rosenfeld SI. Clin Immunol Immunopathol; 1989 Mar 01; 50(3):385-93. PubMed ID: 2917425 [Abstract] [Full Text] [Related]
6. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets. Marney SR, Colley DG, Des Prez RM. J Immunol; 1975 Feb 01; 114(2 Pt 1):696-703. PubMed ID: 804512 [Abstract] [Full Text] [Related]
7. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets. Dixon RH, Rosse WF. J Clin Invest; 1977 Feb 01; 59(2):360-8. PubMed ID: 833281 [Abstract] [Full Text] [Related]
8. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM. J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297 [Abstract] [Full Text] [Related]
9. Clq inhibition of the interaction of collagen with human platelets. Cazenave JP, Assimeh SN, Painter RH, Pachham MA, Mustard JF. J Immunol; 1976 Jan 01; 116(1):162-3. PubMed ID: 1245737 [Abstract] [Full Text] [Related]
14. Platelet-serotonin release by C3a and C5a: two independent pathways of activation. Meuer S, Ecker U, Hadding U, Bitter-Suermann D. J Immunol; 1981 Apr 01; 126(4):1506-9. PubMed ID: 7204973 [Abstract] [Full Text] [Related]
16. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. Taylor FB, Müller-Eberhard HJ. J Clin Invest; 1970 Nov 01; 49(11):2068-85. PubMed ID: 4248913 [Abstract] [Full Text] [Related]
18. Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction. Sundsmo JS, Fair DS. Clin Physiol Biochem; 1983 Nov 01; 1(2-5):225-84. PubMed ID: 6241121 [No Abstract] [Full Text] [Related]
19. Effect of heterologous antibody on human platelets. Colman RW, Schreiber AD. Blood; 1976 Jul 01; 48(1):119-31. PubMed ID: 947400 [Abstract] [Full Text] [Related]
20. Effect of anti-P1A1 antibody on human platelets. I. The role of complement. Cines DB, Schreiber AD. Blood; 1979 Apr 01; 53(4):567-77. PubMed ID: 570843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]